HSCS:NASDAQ, HeartSciences Inc.
HSCS stock overview
HeartSciences Inc. (HSCS:NASDAQ) closed at $3.20 on October 23, 2026,
up 0.95% on the day.
The stock trades 39.0% below its 52-week high of $5.25
and 96.3% above its 52-week low of $1.63.
Over the past year, it lost 2.8%.
HeartSciences Inc. is part of the Health Care sector.
Key figures
- Price
- $3.20
- Day change
- +0.95%
- Volume
- 15,921
- Average volume
- 163,681
- Market cap
- 15M+
- 52-week range
- $1.63 – $5.25
- 50-day average
- $3.48
- 200-day average
- $2.71
Price action over the past year
In 252 trading sessions since October 22, 2025, HSCS closed higher on 105 days (42%).
Its best day was June 23, 2026 (+55.37%) and its worst was November 21, 2025 (-18.90%).
The stock moved 10% or more in a single session 27 times.
It opened at least 5% above the previous day's high 1 time.
Recent signals
HSCS news
-
Oct 22, 2026:
Is HeartSciences Inc. (HSCS) Stock Outpacing Its Medical Peers This Year?
-
Oct 21, 2026:
HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
-
Oct 14, 2026:
Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings
-
Oct 13, 2026:
Thermo Fisher to Report Q3 Earnings: What's in the Cards?
-
Oct 6, 2026:
Fortitude Doubles Down on Zcash Mining With $100M BITMAIN Commitment
-
Oct 6, 2026:
HeartSciences Receives FDA 510(k) Clearance for its MyoVista wavECGTM Device
-
Oct 6, 2026:
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
-
Oct 5, 2026:
Fortitude Secures Priority Supply Allocation for BITMAINs Next-Generation Zcash Mining Equipment, Announces $100 Million Non-Binding Purchase Commitment, and Additional Upsizing of DCG Credit Facility and Available ZEC Funding from DCG
About HeartSciences Inc.
Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
Similar stocks
Find more stocks like HSCS with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.